PLTR reported earnings yesterday after the close. After TSLA, this is our next highest rated stock with calls to match, across both the PRO and Premium Trading Services. Let's take a look at the chart and our recommended options and consider what, if anything should be done with these positions. Earnings Summary "Palantir Technologies announced its financial results for Q4 2024, revealing a 36% year-over-year revenue increase to $828 million, significantly surpassing expectations. The U.S. market contributed notably with a 52% revenue growth, split between a 64% rise in commercial revenue and a 45% increase in government revenue. The company's adjusted operating margin reached 45%, achieving a Rule of 40 score of 81%. For fiscal year 2025, Palantir forecasted a 31% revenue growth, which was well above consensus estimates. This led to the stock price hitting an all-time high, exceeding $100 in after-hours trading. The strong performance was attributed to strategic advancements in AI and significant customer expansion, particularly in the U.S. commercial sector." ----- PLTR 240 Minute Shares are up 25% this morning in the wake of a stellar earnings report. Look for some backing and filling this week, but ultimately this name will be in our B&H and Trading portfolios for a long, long, time. Wave 5 Targeting $200+. PLTR 120 Minute PLTR: Unexpired Options PRO Service Premium Service Find Something That Works...Then Trade It We've explored numerous ways to manage PLTR option strategies, from simple buying and holding through expiration, to pyramiding shorter-term strikes and expirations, to periodically taking half off of triple digit gains and rolling remainder up to new strikes/expirations. Over the past two years we've been trading PLTR from the mid-teens to triple digits today and now will trade it into the $200's using the same smorgasbord of option trade management. Palantir Erupts On Big Earnings Beat; Next Phase Of AI Is Application Layer HIMS: SPECIAL SITUATION Hims & Hers Set To Run Impactful Super Bowl Ad Click on the headline above for the fundamental reason to buy calls on HIMS before the Super Bowl on Sunday. For the technical reasons, here is my chart with a basic five-wave target window for price appreciation potential over the next few weeks. HIMS This stock has tripled since September and that is without a Super Bowl ad. Wave 3 is the most dynamic leg up, so the Fibonacci extension tool targeting $54-$72 is not unrealistic, with timing the only real question market. By Feb expiration? Maybe. By March expiration, more likely. Let's look at calls for both expirations: RFK, Jr. Bonus: A heated confirmation hearing to approve RFK, Jr for Secretary of Health and Human Services adds more publicity, in this instance free publicity, for HIMS. You don't have to be for or against RFK, Jr. to take advantage of public awareness of global health issues. HIMS wins, either way, although we are buying here mostly for the Super Bowl ad pump. Too lazy to read linked article? Here's the 60 second spot: HIMS 60 Super Bowl Commercial .
